Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Diet Liberalization After Anterior Lumbar Interbody Fusion Improves Postoperative Recovery.
Bridges T, Meade M, Brush P, Lee Y, Narayanan R, McCurdy MA, Lambrechts M, Charlton A, Jenkins E, Juniewicz R, Destine H, Kaye ID, Kurd M, Canseco J, Hilibrand A, Vaccaro AR, Schroeder G, Kepler C. Bridges T, et al. Global Spine J. 2023 Dec 27:21925682231223461. doi: 10.1177/21925682231223461. Online ahead of print. Global Spine J. 2023. PMID: 38149647 Free article.
Trigger Finger Release: Are Sutures Requiring Removal Necessary?
Bridges TN, Kasper AA, Sherman MB, Matzon JL, Ilyas AM. Bridges TN, et al. J Hand Surg Glob Online. 2023 Aug 4;5(6):740-743. doi: 10.1016/j.jhsg.2023.06.010. eCollection 2023 Nov. J Hand Surg Glob Online. 2023. PMID: 38106928 Free PMC article.
Mechanical Complications of Hip and Knee Spacers Are Common.
Costanzo J, McCahon J, Tokarski AT, Deirmengian C, Bridges T, Fliegel BE, Deirmengian GK. Costanzo J, et al. Among authors: bridges t. Cureus. 2023 May 3;15(5):e38496. doi: 10.7759/cureus.38496. eCollection 2023 May. Cureus. 2023. PMID: 37273394 Free PMC article.
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens.
Gupta S, DeAngelo J, Melamed I, Walter JE, Kobayashi AL, Bridges T, Sublett JW, Bernstein JA, Koterba A, Manning M, Maltese J, Hoeller S, Turpel-Kantor E, Kreuwel H, Kobayashi RH. Gupta S, et al. Among authors: bridges t. J Clin Immunol. 2023 Aug;43(6):1414-1425. doi: 10.1007/s10875-023-01509-4. Epub 2023 May 9. J Clin Immunol. 2023. PMID: 37160610 Free PMC article.
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
264 results